Disease Info Card

Acral Lentiginous Malignant Melanoma

Information about Acral Lentiginous Malignant Melanoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Acral Lentiginous Malignant Melanoma

Most recent studies have shown that Acral Lentiginous Malignant Melanoma shares some biological mechanisms with cell-invasion, cutaneous-melanoma, foot-diseases, hutchinsons-melanotic-freckle, lentigo, lentigo-maligna-melanoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanocytic-nevus, melanoma, metastatic-melanoma, nail-diseases, neoplasm-invasiveness, neoplasm-metastasis, neoplasms, nodular-melanoma, skin-neoplasms, stage-0-skin-melanoma, superficial-spreading-malignant-melanoma-of-skin, ulcer.

Among the many pathways, these few ones have gauged particular interests from scientists studying Acral Lentiginous Malignant Melanoma, and have been seen in publications frequently: Cell Death, Cell Proliferation, Flight, Lateral Growth, Localization, Pathogenesis, Pigmentation, Rna Interference, Wound Healing

Quite a number of genes have been found to play important roles in Acral Lentiginous Malignant Melanoma, such as ANKRD36B, BRAF, CDKN2A, CSPG4, DSP, KIDINS220, KIT, MID1, MITF, MLANA, MYC, NQO1, NRAS, POMC, PTEN, PTGDR, TNFSF14, TYR, ZNF654. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.